Data protection Impressum

Diagnostic

The third building of the site was inaugurated in the presence (from left to right) of Stéphane Coppey, the President of the City of Monthey, Christophe Darbellay, Head of the Department of Economy and Education, and Jean-Marc Tornare, President of BioArk.

BioArk Monthey’s third building signifies exponential growth in the life sciences sector

16 October 2023

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism.

Adiposs completes the phase I clinical trial of its flagship product ImageBAT

11 October 2023

Nagi Bioscience is at the cusp of redefining the landscape of next-generation drug discovery and chemical testing technologies, placing humane testing solutions within arm’s reach of the global scientific community.

Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing

3 October 2023

bNovate raises CHF 12 million to enhance global water safety

20 June 2023

Alithea Genomics secures CHF 500,000 to boost RNA sequencing technology

27 March 2023

Alithea Genomics and CHUV to help make immunotherapy treatments more targeted

30 January 2023

The University of Fribourg unveils bioinspired nanosensors for early detection of cancer

18 January 2023

Calciscon enters Eurostars project to improve patient care worldwide

17 January 2023

Researchers from Bern unveil a painless and reliable allergy test

4 May 2022

1 2 3 4